• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN SPIDER FX; CATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN SPIDER FX; CATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Paresis (1998)
Event Date 05/01/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
A representative case is reported of a plaque with acute intraplaque hemorrhage.Images were obtained from a (b)(6) man with asymptomatic carotid artery stenosis.This patient experienced amaurosis fugax after carotid artery stenting.Acute intraplaque hemorrhage appears hyperintense on hyper t1-weighted images and isointense to hypointense on t2-weighted multicontrast atherosclerosis characterization images.A small quantity of hemorrhagic debris was captured.Preoperative diffusion-weighted imaging showed no ipsilateral acute infarction in parietal lobe.Two new diffusion-weighted imaging lesions were observed in the same transverse plane.The purpose of this retrospective study was to identify which stage of intraplaque hemorrhage (iph) is an independent risk factor for ipsilateral new ischemic lesions (nils) after carotid artery stenting (cas).Two antiplatelet agents were administered for at least 7 days before cas.All the procedures were performed under local anaesthesia via the percutaneous transfemoral route.An intravenous heparin bolus based on the patient¿s weight was given for intraoperative anticoagulation.Two different types of embolic protection device (epd) were used one of which was the spiderfx.Pre-dilation was performed with a percutaneous transluminal angioplasty balloon catheter placed across the stenosis before deploying the stent.Two types of non-medtronic stents were placed in the stenotic lesion: open cell or closed cell.Post-dilation was performed to ensure that the residual stenosis was <(> <<)>30%.All the patients received neurologic evaluation during and after the procedures.The intraoperative evaluation consisted of consciousness and contralateral limb function tests during the steps including common carotid artery cannulation, epd lesion crossing, stent crossing, stent implantation, pre-dilation, and post-dilation.The debris captured by the epds was also observed after the procedures.Mri examinations were performed 3 days before the operation.All mris were independently reviewed by 2 radiologists with 3- and 6-years¿ experience in carotid mri who were blinded to the patients¿ clinical history and results of other diagnostic tests.If there was reviewer discrepancy, a consensus decision was made.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPIDER FX
Type of Device
CATHETER, CAROTID, TEMPORARY, FOR EMBOLIZATION CAPTURE
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
IE  
091708734
MDR Report Key10181396
MDR Text Key201037630
Report Number2183870-2020-00187
Device Sequence Number1
Product Code NTE
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K063204
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/04/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age78 YR
-
-